
Bioorganic and Medicinal Chemistry Letters p. 2773 - 2778 (1999)
Update date:2022-08-02
Topics:
Chambers
Marfat
Antognoli
Cheng
Damon
Kuperman
Liston
Mebus
Pillar
Shirley
Watson
CP-199,330 (3) and CP-199,331 (4) are cysLT1 receptor antagonists that are equipotent to marketed cysLT1 receptor antagonists zafirlukast and pranlukast, show good pharmacokinetics in rats and monkeys, and are devoid of liver toxicity in monkeys as seen in CP-85,958 (1).
View Morewuxi leji biology technology co., LTD
website:http://www.lejibio.com/
Contact:18362718864
Address:The Nanyue Road No. 2, Yixing City, Jiangsu Province
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376,63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Huangshi Shennong Chemical Technology Co., Ltd
Contact:+86-714-3072290
Address:Eastern industrial park , Tieshan district , Huangshi city ,Hubei province , China
Contact:0027-717-456976
Address:2ND FLOOR, 325 VAUSE ROAD, OVERPORT, 4001, SOUTH AFRICA
Shanghai agrotree chemical co.,ltd.
Contact:+86-21-50117563
Address:Room 8A,liangfeng building,No.8 dongfang RD.pudong,shanghai,China
Doi:10.1039/jr9410000547
(1941)Doi:10.1002/jlcr.3073
(2013)Doi:10.1039/c3tc32388a
(2014)Doi:10.1016/j.tetlet.2014.02.024
(2014)Doi:10.1134/S1070363214020170
()Doi:10.1002/cctc.201300640
(2014)